1. Home
  2. KOP vs AURA Comparison

KOP vs AURA Comparison

Compare KOP & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koppers Holdings Inc.

KOP

Koppers Holdings Inc.

N/A

Current Price

$30.18

Market Cap

784.7M

ML Signal

N/A

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

N/A

Current Price

$6.57

Market Cap

631.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOP
AURA
Founded
1988
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
784.7M
631.6M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
KOP
AURA
Price
$30.18
$6.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $56.00
$16.60
AVG Volume (30 Days)
127.2K
★ 854.5K
Earning Date
11-06-2026
11-16-2026
Dividend Yield
★ 0.91%
N/A
EPS Growth
★ 11.38
N/A
EPS
N/A
★ N/A
Revenue
★ $1,879,300,000.00
N/A
Revenue This Year
$2.85
N/A
Revenue Next Year
$4.53
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.02
$4.73
52 Week High
$53.00
$9.54

Technical Indicators

Market Signals
Indicator
KOP
AURA
Relative Strength Index (RSI) 20.57 53.85
Support Level N/A $6.04
Resistance Level $39.19 $6.90
Average True Range (ATR) 1.87 0.32
MACD -0.47 0.04
Stochastic Oscillator 33.61 76.97

Price Performance

Historical Comparison
KOP
AURA

About KOP Koppers Holdings Inc.

Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: